Abstract
Background COVID-19, caused by SARS-CoV-2, is highly contagious and causes substantial morbidity and mortality. Mask usage has been advocated by health professionals to minimize its spread. Thus, it is important to develop a simulation that models SARS-CoV-2 spread in indoor environments to evaluate mask usage effectiveness.
Methods A visual computer simulation was developed with Pygame in Python 3. A virtual indoor supermarket is simulated by a given flow of customers with an initial infection percentage and mask usage percentage who enter, move around, and exit a supermarket with shelves, tables and cashiers to demonstrate a system’s dynamic complexity, i.e. nonlinear interactions of system elements over time. A supermarket was simulated with initial infection rates of 5%, 10%, and 20% and mask use percentages of 0%, 25%, 50% 75%, and 100%. The environmental settings (e.g. shelf number and location) and total customers (N=200) were kept constant.
Results The number of infected customers increased as the percentage of mask usage decreased (p < 0.01). At 5% initial infection, almost no infections were observed at 50% mask usage, with a logarithmic best-fit model (R2 = 0.947). At 10% initial infection, the association between mask usage and decrease in number of infections was best fit with a linear model (R2 = 0.924). For 20% initial infection, a quadratic model was the best fit (R2 = 0.934). While a linear model suggests proportional decreases in infection, the quadratic model suggests more significant reductions in infections at higher rates of mask use (i.e. increasing mask usage from 5% to 10% is less impactful than from 65% to 70%).
Conclusion The results suggest that mask usage has a significant impact on decreasing COVID-19 transmission. Ideally, mask usage should be as high as possible to achieve more significant reductions in COVID-19 infections. Various parameters can be adjusted during simulation as we learn more about SARS-CoV-2 to guide policies for minimizing COVID-19 transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There was no IRB/oversight body because there were no human subjects.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The study consisted of computer simulated data which will not be provided.
